Lv71
3380 积分 2023-05-12 加入
Final, 10-Year Outcomes with Nivolumab plus Ipilimumab in Advanced Melanoma
5个月前
已完结
Hijacking antibody-induced CTLA-4 lysosomal degradation for safer and more effective cancer immunotherapy
5个月前
已完结
Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia
9个月前
已完结
A novel continuous erythropoietin receptor activator (C.E.R.A.) for the treatment of anemia in patients with chronic kidney disease: Pharmacokinetic and pharmacodynamic studies
9个月前
已关闭
皖公网安备34019202002308
